Page 5 - Bracanalysis Cdx News Today

The firm reported total revenues of $160.8 million in the quarter, all from molecular diagnostic test sales, but came in below analysts' consensus estimate due to COVID-19 headwinds.

SALT LAKE CITY, Feb. 16, 2022 -- Myriad Genetics, Inc., a leader in genetic testing and precision medicine, will hold its 2021 fourth-quarter earnings conference call on Thursday, February 24,... | February 16, 2022

SALT LAKE CITY, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will be...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Singular Genomics: Elaine Mardis Singular Genomics has added Elaine Mardis to its board of directors. Since 2016, Mardis has served as co-executive director of the Institute of Genomic Medicine at Nationwide Children's Hospital, and holds the Steve and Cindy Rasmussen endowed chair in genomic…

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

SALT LAKE CITY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Many Americans are experiencing anxiety symptoms as a result of the pandemic. Yet, one in five say they...

Share: SALT LAKE CITY, May 19, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced that it will present results from a study with more than 275,000 women validating the use of a new method for polygenic breast cancer risk assessments in women of all ancestries. The new data will be shared in an oral presentation with leading collaborators on June 4 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meet...

Share: SALT LAKE CITY, May 03, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced that it has entered into a definitive agreement to sell select operating assets and intellectual property (IP), including the Vectra® test, from Myriad Autoimmunes business unit to Labcorp (NYSE:LH) for $150 million in cash. Labcorp is a leading global life sciences company and one of the nations largest laboratory service providers. "Our ...

SALT LAKE CITY, April 28, 2021 (GLOBE NEWSWIRE) -- In a new nationwide poll, the GeneSight ® Mental Health Monitor found that 83% of people with depression agree that life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment. “Depression is one of the most misunderstood disorders. When people misinterpret patients with depression as ‘lazy’ or ‘dramatic,�...